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Trypanosome parasites control their virulence and
spread by using quorum sensing (QS) to generate
transmissible ‘‘stumpy forms’’ in their host blood-
stream. However, the QS signal ‘‘stumpy induction
factor’’ (SIF) and its reception mechanism are un-
known. Although trypanosomes lack G protein-
coupled receptor signaling, we have identified a
surface GPR89-family protein that regulates
stumpy formation. TbGPR89 is expressed on blood-
stream ‘‘slender form’’ trypanosomes, which receive
the SIF signal, and when ectopically expressed,
TbGPR89 drives stumpy formation in a SIF-
pathway-dependent process. Structural modeling
of TbGPR89 predicts unexpected similarity to oligo-
peptide transporters (POT), and when expressed
in bacteria, TbGPR89 transports oligopeptides.
Conversely, expression of an E. coli POT in trypano-
somes drives parasite differentiation, and oligopepti-
des promote stumpy formation in vitro. Furthermore,
the expression of secreted trypanosome oligopepti-
dases generates a paracrine signal that accelerates
stumpy formation in vivo. Peptidase-generated oli-
gopeptide QS signals being received through
TbGPR89 provides a mechanism for both trypano-
some SIF production and reception.INTRODUCTION
G protein-coupled receptors (GPCRs) and other multipass-
transmembrane proteins allow eukaryotic cells to perceive
an enormous diversity of extracellular signals, enabling their
response to environmental information. Conventionally, GPCRs
signal through trimeric G proteins to activate intracellular
signaling pathways and are an intense target of drug develop-
ment for the pharmaceutical industry (Gutierrez and McDonald,
2018). However, GPCRs and their cognate signaling compo-
nents are not ubiquitous throughout eukaryota, being absent inCell 176, 1–12, J
This is an open access article undred and green algae, some chromalveolates, and most excavata
(Bradford et al., 2013). Excavates contain a wide variety of
important eukaryotic microbial pathogens, including the kineto-
plastida comprising Leishmania and Trypanosoma parasites. Of
these, Trypanosoma brucei spp., causing human and animal
trypanosomiasis, live extracellularly in the bloodstream of their
mammalian host and exploit environmental information to regu-
late their virulence and transmissibility. Specifically, morpholog-
ically ‘‘slender form’’ bloodstream trypanosomes proliferate until
signaled to undergo development to non-proliferative ‘‘stumpy
forms’’ adapted for transmission (MacGregor et al., 2012). This
is a quorum-sensing (QS) type response triggered by the accu-
mulation of a ‘‘stumpy induction factor’’ (SIF), although the na-
ture and mechanism of signaling remains unknown (Reuner
et al., 1997; Vassella et al., 1997). Recently, components of the
SIF response pathway were uncovered by a genome-wide
RNAi screen that identified signal transduction components
and gene expression regulators controlling stumpy formation
(Mony et al., 2014). However, molecules at the cell surface that
detect or transport SIF, or act at early steps in the signaling
pathway, remain completely unknown, as is the SIF signal that
drives QS.
In plants, GTG1 and GTG2, members of the GPR89 protein
family that are classified as orphan GPCRs, detect the extracel-
lular phytohormone abscisic acid (Pandey et al., 2009). In
mammalian cells, GPR89 acts as an anion channel protein that
is involved in Golgi pH homeostasis (GPHR, Golgi pH regulator)
(Maeda et al., 2008). More recent studies suggest GPR89 family
members have a location in the Golgi and ER in Dictyostelium
(Deckstein et al., 2015), with mutants exhibiting developmental
defects and perturbed secretory function. In each case, the
GPR89 proteins have 9 transmembrane domains (TMDs),
distinct from the 7 TMDs conventionally found in GPCRs, and
structural bioinformatics analysis has supported the distinction
of plant GTGs from the GPCR family (Taddese et al., 2014). Rep-
resentatives of GPR89 are found in each of the currently recog-
nized supergroups, although they appear to be missing in some
organisms, including certain species of fungi and the pathogenic
apicomplexan Cryptosporidium.
Here, we report the presence of a GPR89 representative,
TbGPR89, in the kinetoplastid parasite, Trypanosoma brucei.
This surface protein is expressed on the parasite stage thatanuary 10, 2019 ª 2018 The Author(s). Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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SIF signaling pathway. African trypanosomes lack conventional
oligopeptide transporters, but we show that TbGPR89 can trans-
port oligopeptides, which promote stumpy formation in vitro.
Furthermore, the expression of secreted oligopeptidases by
trypanosomes generates a paracrine signal to co-infecting
trypanosomes, driving premature stumpy formation in vivo. Our
data invoke oligopeptide signals received via TbGPR89 as the
long-soughtmechanismof trypanosome quorum sensing. These
findings provide a novel therapeutic target for trypanosomes
that is potentially refractory to the emergence and spread of
resistance.
RESULTS
Tb927.8.1530 Encodes a GPR89 Family Protein
Bioinformatic analysis of the trypanosomatid genomes identified
genes encoding representatives of the GPR89 family (Figures
S1A and S1B). For Trypanosoma cruzi TriTrypDB: TcCLB.
508547.140, BLASTP detected similarity scores of 1.1e16
and 2.3e16 to A. thaliana GTG1 and GTG2, respectively, and
4.1e10 to mammalian GPR89 (GPHR). The syntenic T. brucei
gene, TriTrypDB: Tb927.8.1530, is predicted to encode
9-TMDs (Tsirigos et al., 2015) and a large central loop (http://
wlab.ethz.ch/protter/start) (Figure 1A). All trypanosome family
GPR89 family members contain a 70 amino acids GPHR_N
(PFAM12537) domain with a conserved LSG motif in the
N-terminal 5TM region of mammalian GPHR (http://smart.
embl-heidelberg.de). An ABA-GPCR domain (PFAM12430,
associated with abscisic acid binding in GTG1) is also present
in most kinetoplastid GPR89 homologs (TriTrypDB: TcCLB.
508547.140, E value = 8.5e16) but is not detected in TbGPR89
of T. brucei (Figure S1C).
TbGPR89 Is a Slender Specific Protein that Induces
Stumpy Formation via the SIF Signaling Pathway
An antibody targeting TbGPR89 detected expression on blood-
stream slender but not on stumpy forms at the cell surface
(Figures 1B and 1C). To explore the function of the protein, we
transfected parasites with a plasmid driving the doxycycline-
inducible ectopic-expression of TbGPR89. In T. brucei Lister
427 90:13 monomorphic cells (Wirtz et al., 1999), which have
lost the capacity for stumpy formation through serial passage,
the protein was effectively expressed but there was only a subtle
effect on cell growth (Figure 1D). However, when the protein was
inducibly expressed in developmentally competent pleomorphic
trypanosomes, T. brucei EATRO 1125 AnTa1.1 90:13, the para-
sites underwent rapid growth arrest in G1 (Figures 1E and 1F) as
the cells became morphologically stumpy (Figure 1G). This rep-
resented significantly accelerated differentiation compared to
the normal differentiation kinetics of wild-type parasites (i.e.,
stumpy formation in 24 hr rather than >72 hr). In contrast to
monomorphic parasites, the protein expression was transient,
being detected 4 hr after induction but reduced at 24 hr
(compare Figure 1D and 1E), consistent with the developmental
loss of the protein in stumpy forms.
To establish the physiological relevance of the TbGPR89-
induced arrest in pleomorphic parasites, trypanosomes were2 Cell 176, 1–12, January 10, 2019grown in vivo. After 24 hr induction, the parasites underwent
rapid growth arrest (Figure 2A), accumulating in a 1K1N cell-
cycle configuration (Figure 2B) despite their low parasitemia
compared to uninduced parasites. Induced parasites expressed
the stumpy-specific cell marker PAD1 (Dean et al., 2009) at day 3
post infection (Figure 2C) and, when exposed to 6 mM cis-aco-
nitate, these cells expressed EP procyclin on 69% of cells after
6 hr, reflecting effective differentiation to the next life cycle stage,
procyclic forms. This was equivalent to the stumpy forms gener-
ated at high parasitemia in uninduced parasites (Figure 2D).
Thus, TbGPR89 ectopic expression activates all of the hallmarks
of stumpy forms.
Physiological stumpy formation is signaled through a soluble
parasite-released ‘‘stumpy induction factor’’ (SIF) (Vassella
et al., 1997), whose intracellular signaling pathway has been
recently characterized (Mony et al., 2014). To establish whether
the TbGPR89-mediated differentiation response was enacted
through this pathway, TbGPR89 ectopic expression was
induced in cell lines where RBP7, a predicted RNA binding pro-
tein necessary for SIF-induced stumpy formation (Mony et al.,
2014), was simultaneously and constitutively silenced by RNAi.
Figure 2E shows that inducible TbGPR89 ectopic-expression
caused growth arrest in vitro, whereas simultaneous RBP7
RNAi prevented this, allowing the parasites to continue to grow
unimpeded despite effective expression of TbGPR89. This
demonstrated that TbGPR89-induced arrest is transduced
through the SIF response pathway (Figure 2F).
TbGPR89 Is an Essential Protein
Attempts to deplete TbGPR89 by RNAi were unsuccessful, as
was allelic replacement using drug resistance cassettes tar-
geted to replace both TbGPR89 alleles in the trypanosome’s
diploid genome. We also exploited a CreLox/thymidine ki-
nase-based gene deletion system (Kim et al., 2013) to inducibly
delete both TbGPR89 alleles (Figure S2A). Cre recombinase in-
duction in combination with ganciclovir selection of null mu-
tants resulted in cell death over 5 days (Figures S2A–S2D).
Thus, TbGPR89 is essential in bloodstream slender form
parasites.
Topology modeling and primary sequence analysis of
TbGPR89 predicted a number of potential features: an 125
amino acid intracellular loop containing the PFAM12537/
DUF3735 GPHR family signature, a C-terminal domain with a
predicted SCF ubiquitin ligase binding phospho-degron motif
(http://elm.eu.org/), and a possible N-glycosylation motif at
N67 (Figure S3A). To investigate the importance of these
motifs, we expressed mutant forms of TbGPR89 in which the
C-terminal amino acids 415–482, containing the phosphode-
gron motif, were deleted (DC), the intracellular loop was
deleted and replaced with a 6xHA tag (D Loop), or the poten-
tial glycosylation site was mutated (N67Q). Each was then
ectopically expressed in pleomorphic trypanosomes with the
endogenous TbGPR89 gene intact, and their growth and
stumpy formation assessed (Figures S3B–S3E). Expression
of the C-terminal truncation mutant resulted in death of the
parasites within 3 hr of induction, indicating a dominant-nega-
tive effect (Figure S3B). In contrast, when the D Loop and
N67Q mutants were ectopically expressed, the accelerated
Figure 1. Tb927.8.1530 Encodes a GPR89
Family Member that Promotes Stumpy
Formation
(A) Topology map of TbGPR89 showing the TMDs
predicted using the TOPCONs server (http://
topcons.cbr.su.se) and rendered via Protter
(http://wlab.ethz.ch/protter/start).
(B) Location of TbGPR89 on bloodstream form
trypanosomes. Left: phase contrast image of a
slender bloodstream form trypanosome. Right:
surface staining with anti-TbGPR89 antibody.
Scale bar, 15 mm.
(C) Stage regulation of TbGPR89. Proteins were
isolated from parasite populations enriched in
slender (SL) forms or stumpy (ST) forms. Samples
were reacted with antibodies recognizing
TbGPR89, the stumpy specific marker PAD1 or
EF1a, as a loading control. TbGPR89 runs aber-
rantly with respect to its anticipated molecular
weight (53 kDa), similar to other GPR89 proteins,
likely due to its 9 TMDs and potential post trans-
lational modification.
(D) Growth of monomorphic Lister 427 90:13 par-
asites induced (+DOX) or not (DOX) to express
TbGPR89-Ty. Error bars, SEM. Right: protein
expression of TbGPR89-Ty1 in monomorphic
parasites 4 hr and 24 hr post induction with
doxycycline, detected using the Ty1 epitope-spe-
cific BB2 antibody. Note that ectopically ex-
pressed TbGPR89 predominantly migrates at
<40 kDa perhaps due to the efficiency of post
translational modification and presence of
the epitope tag. Anti EF1a provides the loading
control.
(E) Growth of pleomorphic T. brucei parasites
induced (+DOX) or not (DOX) to express
TbGPR89-Ty. Error bars, SEM. Right: protein
expression of TbGPR89-Ty1 4 hr and 24 hr post
induction with doxycycline. Anti EF1a provides the
loading control.
(F) Cell-cycle status of pleomorphic T. brucei
induced (+DOX) or not (DOX) to ectopically ex-
press TbGPR89 in culture. The proportion of
cells in G1, GS, or G2/M was determined by flow
cytometry.
(G) Morphology of pleomorphic T. brucei cells
induced (+DOX) or not (DOX) to express
TbGPR89-Ty1 in culture for 24 hr. DAPI stains the
cell nucleus and kinetoplast. Scale bar, 10 mm.
See also Figure S1.
Please cite this article in press as: Rojas et al., Oligopeptide Signaling through TbGPR89 Drives Trypanosome Quorum Sensing, Cell (2019),
https://doi.org/10.1016/j.cell.2018.10.041stumpy induction phenotype of wild-type TbGPR89 was lost
and cells continued to proliferate (Figures S3C and S3D). To
assess the N67Q mutant in more detail, we generated a
Cas9 expressing T. brucei pleomorphic line (T. brucei EATRO
1125 AnTat1.1 J1339) and used CRISPR technology to replace
the wild-type TbGPR89 alleles with the N67Q mutant gene
(allele 1) and a hygromycin resistance gene (allele 2). Indepen-
dent selected cell lines had integrated the HygR gene and
the N67Q mutant allele but retained an additional wild-
type gene copy, supporting the mutant being nonfunctional
(Figure S3F). These cells showed increased growth in vivo
compared to wild-type TbGPR89, reflecting delayed differenti-
ation (Figure 2G).These results, summarized in Figure 2H, demonstrated
that the accelerated differentiation phenotype generated by
TbGPR89 ectopic expression was not simply a consequence
of perturbation of the trafficking architecture of the cells, but
rather a response resulting from the expression of a surface
protein whose function was dependent on its sequence integ-
rity. Furthermore, N67Q/WT cell line analysis supported a role
for TbGPR89 in physiological SIF reception and stumpy
formation.
TbGPR89 Can Transport Oligopeptides
Assignment of TbGPR89 to the GPR89 family of proteins was
based upon its overall BLAST similarity and conservation ofCell 176, 1–12, January 10, 2019 3
Figure 2. TbGPR89 Expression Drives
Stumpy Formation through the SIF Signaling
Pathway
(A) Parasitemia of pleomorphic T. brucei parasites
induced (+DOX) or not (DOX) to ectopically ex-
press TbGPR89 in vivo. TbGPR89 expression was
induced 24 hr post infection by doxycycline (ar-
rowed). n = 3 per group.
(B) The percentage of cells with 1K1N or 2K1N
plus 2K2N on days 1–3 post infection in the
presence or absence of TbGPR89 ectopic ex-
pression. n = 3; 250 cells per time point. Error
bars, SEM.
(C) Expression of the stumpy marker PAD1 is
elevated when TbGPR89 expression is induced.
Slender parental T. brucei EATRO 1125 AnTat1.1.
90:13 (‘‘90-13’’) provides the negative control.
(D) Expression of EP procyclin on parasites har-
vested from bloodstream infections and exposed
to the differentiation signal, 6 mM cis-aconitate.
The stumpy form parasites induced to express
TbGPR89 (red bars) differentiated as efficiently to
procyclic forms as uninduced stumpy forms (blue
bars), despite being arrested at lower parasitemia.
Independent slender (black bars) and stumpy
forms (white bars) provide negative and positive
controls, respectively. Error bars, SEM.
(E) TbGPR89 expression arrests growth of pleo-
morphic trypanosomes grown in vitro (n = 3) but
does not arrest growth when RBP7 expression is
silenced by RNAi (n = 3). Error bars, SEM. Unin-
duced and induced RBP7 RNAi lines were
passaged every 24 hr to show that cells continue to
proliferate in the presence of TbGPR89 over-
expression, as with monomorphic cells. Right:
TbGPR89-Ty1 expression in the RBP7 RNAi cells;
anti-paraflagellar rod protein is used as a loading
control.
(F) Representation of the stumpy formation
pathway. Components of the SIF-dependent
pathway (C1, C2) also include identified mole-
cules such as RBP7, whose silencing inactivates
the pathway (Mony et al., 2014). Hence, if
TbGPR89-induced stumpy formation is inhibited
by RBP7 RNAi, signaling via the SIF pathway is
indicated. If not, SIF-independent signaling
pathway is implicated.
(G) Parasitemia of pleomorphic parental cells and
the TbGPR89 WT/N67Q mutants generated by
CRISPR. Results from two independent mutant cell lines are shown, both exhibiting elevated parasitemia and delayed differentiation compared to the parent line.
Error bars, SEM.
(H) Summary of phenotypes generated upon ectopic expression of TbGPR89 mutants detailed in Figure S3.
See also Figures S2 and S3.
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this or other protein families, TbGPR89 was subjected to struc-
tural homology modeling via iTASSER (iterative threading
assembly refinement) (Roy et al., 2010) previously used to inves-
tigate predicted Arabidopsis GPCR proteins (Taddese et al.,
2014). Surprisingly, searches revealed structural similarity to
voltage-gated ion channels and the POT family of proton-
coupled oligopeptide transporters in the substrate recognition
region (Figures 3A, S4A, and S4B). POT family transporters are
present in a wide range of prokaryotes and eukaryotes and
are linked to small molecule uptake. However, a conventional4 Cell 176, 1–12, January 10, 2019POT gene is missing in African trypanosomes (T. brucei,
T. congolense, T. vivax) but not other kinetoplastid species (Fig-
ure 3B) leading us to hypothesize that TbGPR89 may replace
POT function in these parasites. Therefore, we expressed
TbGPR89 in E. coli under IPTG-inducible control and monitored
the uptake of the fluorescent dipeptide b-Ala-Lys-AMCA
compared to the well-characterized E. coli POT, YjdL (Ernst
et al., 2009). Figure 3C shows uptake of the dipeptidomimetic
in E. coli that inducibly express TbGPR89. Supporting a
transport function for TbGPR89, uptake was non-saturable
up to 4 mM, increased over time, and was reduced by the
Figure 3. TbGPR89 Transports Oligo-
peptides
(A) Homology modeling of TbGPR89 and
the G. kaustophilus POT protein. Superimposition
of the TbGPR89 model (green) onto the
G. kaustophilus template (purple), centered on the
dipeptide analog alafosfalin binding pocket (resi-
dues of which are shown as lines). Side chains of
TbGPR89 residues within interaction distance of
the ligand are shown as thicker lines. Potential
H-bonds between the model and the ligand are
highlighted by dashed yellow lines. The predicted
substrate interacting tyrosine 48 in TbGPR89 is
annotated.
(B) Representation of the syntenic regions of the
genomes of respective kinetoplastid organisms,
with the location of a conventional POT family
member highlighted in orange. This is missing in
African trypanosomes.
(C) Relative uptake of fluorescent dipeptide b-ALA-
Lys-AMCA in E. coli induced (+IPTG) or not
induced (IPTG) to express TbGPR89, E. coliYjdL,
or an empty plasmid control. Fluorescence is in
arbitrary units. n = 3; error bars, SEM.
(D) Mutation of the predicted dipeptide interacting
residue tyrosine 48 to histidine 48 in TbGPR89
reduces transport of the fluorescent dipeptide
b-Ala-Lys-AMCA when expressed in E. coli. Fluo-
rescence is in arbitrary units. n = 3; error
bars, SEM.
(E) Wild-type and Y48H mutant TbGPR89 are ex-
pressed at equivalent levels in induced (+IPTG)
and uninduced (IPTG) E. coli.
See also Figure S4.
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ophenyl hydrazone and at 4C (Figures S4C–S4E).
Examination of the potential substrate interacting region in
TbGPR89 and Geobacillus kaustophilus POT, centered on the
binding pocket of the dipeptide analog, alafosfalin (Doki et al.,
2013) positioned tyrosine 48 in TbGPR89 at a corresponding
location to tyrosine 78 in the peptide-binding site of G. kausto-
philus POT (Figure 3A). When TbGPR89 tyrosine 48 wasmutated
to histidine (Y48Hmutant) and tested for b-Ala-Lys-AMCA trans-
port capability in E. coli, uptake was reduced 40% (Figure 3D)
despite equivalent expression of the wild-type and mutant pro-
tein (Figure 3E). This supported the oligopeptide transport func-
tion of TbGPR89.
Having demonstrated that TbGPR89 has oligopeptide trans-
porter activity, we explored whether a heterologous oligopeptide
transporter expressed in trypanosomes could promote stumpyformation. Therefore, we expressed Ty1
epitope-tagged E. coli YjdL in pleomor-
phic trypanosomes under doxycycline-
regulated control and observed growth
arrest in vitro within 24 hr (Figure 4A). In
this case, protein expression was re-
tained over 72 hr, rather than being
lost beyond 24 hr as in TbGPR89 ectopic
expression (compare Figures 4B and 1E),presumably due to absence of the phospho-degron domain in
the heterologous protein. Furthermore, the YjdL protein was de-
tected at the cell surface (Figure 4C). Induction of E. coli YjdL
expression also induced rapid growth arrest in vivo (Figure 4D)
and the generation of morphological stumpy forms that had a
characteristic branched mitochondrion (Figure 4E) and were
competent for differentiation to procyclic forms (Figure 4F). Sup-
porting a role for oligopeptide transport in the parasite response,
ectopic expression of an E388A mutant of YjdL with reduced
transport capability (Ernst et al., 2009) resulted in reduced
growth arrest and stumpy formation compared with intact YjdL
(Figure 4G).
Oligopeptides Promote Stumpy Formation In Vitro
The demonstration that the ectopic expression of both TbGPR89
and a bacterial oligopeptide transporter in trypanosomesCell 176, 1–12, January 10, 2019 5
Figure 4. Expression of a Bacterial POT in
Trypanosomes Induces Stumpy Formation
(A) Expression of E. coli YjdL arrests growth of
pleomorphic T. brucei in vitro when induced with
doxycycline. n = 3 per group; error bars, SEM.
(B) Expression of E. coli YjdL assessed by western
blotting 48 hr and 72 hr after induction with
doxycycline. PAD1 indicates stumpy formation,
evident in the high density uninduced samples and
the low density induced samples. Anti-EF1a pro-
vides a loading control.
(C) E. coli YjdL (green) is located on the trypano-
some cell surface when expression is induced.
AMCA-sulfo-NHS (in blue) labels the parasite
surface and flagellar pocket. Scale bar, 10 mm.
(D) Expression of E. coli YjdL arrests growth of
pleomorphic T. brucei in vivo when induced with
doxycycline. n = 3 +DOX, n = 3 –DOX.
(E) Mitochondrial and cell morphology of pleo-
morphic T. brucei induced or not to express E. coli
YjdL at day 3 of infection. Uninduced cells have a
linear mitochondrion (revealed by MitoTracker
staining, ‘‘Mito’’) characteristic of slender forms
whereas induced parasites show branched mito-
chondrial staining and stumpy form morphology.
Scale bar, 10 mm.
(F) Differentiation to procyclic forms of pleomor-
phic T. brucei after harvest from infection on day 4
and exposure to 6 mM cis-aconitate for parasites
induced (+DOX) or not (DOX) to express E. coli
YjdL. The low parasitemia E. coli YjdL-induced
stumpy cells, and the uninduced high parasitemia
stumpy cells generated by QS differentiated with
similar efficiency. Error bars, SEM.
(G) Expression of an E. coli YjdL E388A mutant in
pleomorphic T. brucei grown in vivo. Reduced
differentiation is observed compared to expres-
sion of the wild-type YjdL (A) despite effective
protein expression (right). The introduced muta-
tion is shown far right. Error bars, SEM.
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tion of oligopeptide signaling to differentiation. First, pleomor-
phic parasites were grown in vitro in the presence of 0% to
15% brain-heart infusion (BHI) broth as a source of oligopepti-
des and the effects on cell proliferation (Figure 5A) and PAD1
expression (Figures 5B and 5C) assayed. In pleomorphic
parasites, stumpy formation was observed in a concentration-
dependent manner; at 48 hr, cells in 0% and 15% BHI supple-
ment were 15% and 82% PAD1+ve, respectively. Monomor-
phic cells, which are unresponsive to SIF, showed less effect
on cell growth under the same conditions (Figure 5A). Other
sources of oligopeptide mixtures also provoked parasite arrest
and PAD1 expression in culture, including animal peptone,6 Cell 176, 1–12, January 10, 2019tryptose, proteose peptone, and vege-
table infusion (Figures 5D and 5E).
To explore oligopeptide-mediated
stumpy formation in more detail, we
chemically synthesized libraries of di-
peptides and tripeptides and tested their
ability to accelerate stumpy formation.Specifically, combinatorial sublibraries of dipeptides or tripepti-
des differentiated by N-terminal specific amino acids (i.e., 16
AA-X dipeptides per sublibrary or 256 AA-X-X tripeptides per
sublibrary) were evaluated, revealing specificity in the response
(Figures 6A–6D). Tripeptides were more potent than dipep-
tides, but the tripeptides with Asn, Gln, His, Phe, Asp, and
Trp at the N terminus were most effective (Figures 6C and
6D). These each arrested growth of the parasites within 48 hr
and resulted in PAD1+ve cells demonstrating their effective
generation of stumpy forms (Figures 6E and 6F). Correspond-
ingly, tripeptides competed more effectively than dipeptides
for b-ALA-Lys AMCA uptake in E. coli expressing TbGPR89
(Figure 6G).
Figure 5. Oligopeptide Mixtures Promote
Stumpy Formation In Vitro
(A) Growth of pleomorphic or monomorphic
T. brucei cells in varying concentrations of auto-
claved brain heart infusion broth at 48 hr. Error
bars, SEM.
(B) PAD1 expression of pleomorphic T. brucei cells
in varying concentrations of autoclaved brain heart
infusion broth at 48h. Error bars, SEM.
(C) Representative images of PAD1 expression and
morphology of pleomorphic cells in varying con-
centrations of BHI broth at 48 hr. PAD1 expression
(in green) is evident on increasing proportions of the
parasites with higher concentrations of autoclaved
BHI; these cells also appear stumpy inmorphology.
The parasite nucleus and kinetoplast (stained with
DAPI) is pseudo colored in magenta. Bar, 25 mm.
(D) Growth of pleomorphic T. brucei in vitro in the
presence of different oligopeptide containing ex-
tracts expressed relative to their growth without
extract (‘‘control’’) at 48 hr. Error bars, SEM.
(E) PAD1 expression of pleomorphic T. brucei
exposed to the different concentrations of
oligopeptide containing extracts at 48 hr. Error
bars, SEM.
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We next explored the relevance of oligopeptide signals in vivo
by manipulating their generation during infections. Trypano-
somes release serum-stable peptidases in vivo, some of which
accumulate at high parasitemia and retain activity in blood
(Bossard et al., 2013). Examples are type I pyroglutamyl
peptidase (TbPGP, TriTrypDB: Tb927.4.2670) that acts on serum
substrates with an N-terminal pyroglutamyl residue (Tables
S1 and S2) (Morty et al., 2006) and prolyl oligopeptidase
(TbPOP; TriTrypDB: Tb927.10.8020), which cleaves after proline
residues (Bastos et al., 2010) (Tables S3 and S4). TbPGP is a
cytosolic peptidase released by lysed parasites during infections
(Morty et al., 2006) whereas TbPOP is reported to be secreted
(Geiger et al., 2010). To determine if the activity of these trypano-
some-derived oligopeptidases in blood could affect stumpy for-
mation, we generated transgenic parasite lines that expressTbPGP or TbPOP with a C-terminal Ty1
epitope and also modified TbPGP with
a BIP N-terminal fusion (BIPN-TbPGP)
promoting extracellular secretion (Bangs
et al., 1996). In vitro, the inducible expres-
sion of TbPGP and BIPN-TbPGP did not
affect cell growth (Figure S5A), indicating
their expression was not deleterious. In
contrast, TbPOP expression slowed
growth and was detectably secreted
(Figures S5B and S5C). Strikingly, how-
ever, pleomorphic cells induced to ex-
press either oligopeptidase in vivo ar-
rested and differentiated to stumpy cells
at lower parasitemia than in uninduced
cells. Moreover, this effect wasmore rapidand pronounced in parasites expressing secreted TbPGP fused
with a BIPN leader than in parasites expressing the native
TbPGP (Figure S6).
We then investigated whether expression of trypanosome oli-
gopeptidases could generate an inter-cellular paracrine signal to
promote differentiation in co-infecting parasites. To test this,
BIPN-TbPGP or TbPOP expressing trypanosome lines were
co-infected with a distinct pleomorphic reporter cell line modi-
fied to encode a Ty1 epitope-tagged paraflagellar rod protein
(Silvester et al., 2017), allowing the visual discrimination of ‘‘pro-
ducer’’ (peptidase secreting) and ‘‘receiver’’ (PFR-Ty1) cells (Fig-
ure 7A). Infections were initiated with PFR-Ty1 cells alone, or
with PFR-Ty1 cells in combination with cells induced or not to ex-
press each oligopeptidase. The parasitemia of resulting infec-
tions and the proportion of ‘‘producer’’ (BIPN-TbPGP or TbPOP)
and ‘‘receiver’’ (PFR-Ty1) cells was then scored, with co-label-
ing for PAD1 identifying the proportion of stumpy cells for eachCell 176, 1–12, January 10, 2019 7
Figure 6. Pleomorphic Trypanosomes
Exposed to Dipeptide or Tripeptide Combi-
nations Terminated in Specific N-Terminal
Amino Acids
(A) The growth of pleomorphic T. brucei exposed to
500 mM dipeptide sublibraries over 72 hr compared
to DMSO. Error bars, SEM.
(B) The growth of pleomorphic T. brucei exposed to
dipeptide sublibrary titrations from 250–62.5 mM
over 72 hr compared to DMSO. Error bars, SEM.
(C) The growth of pleomorphic T. brucei exposed to
125 mM tripeptide sublibraries (at 500 mM, all tri-
peptide sublibraries inhibited growth) over 72 hr
compared to DMSO. Error bars, SEM.
(D) The growth of pleomorphic T. brucei exposed to
tripeptide sublibrary titrations from 250–62.5 mM
over 72 hr compared to DMSO. Error bars, SEM.
(E) PAD1 expression by pleomorphic T. brucei
exposed to 125 mM of the specified tripeptide
sublibraries at 72 hr. Error bars, SEM.
(F) Immunofluorescence image of PAD1 expression
by parasites exposed to 125 mMof the Trp-Aa1-Aa2
sublibrary. Scale bar, 20 mm.
(G) The uptake of b-ALA-Lys-AMCA by E. coli ex-
pressing TbGPR89 in the presence of 2.5 mM
competing unlabeled tri- or dipeptide sublibrary.
Error bars, SEM.
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sion of either BIPN-TbPGP or TbPOP restricted growth of the
total parasite population, which grew to a much lower level
than in a single infection or when peptidase expression was
not induced in the co-infecting population. Despite the lower
overall parasitemia, the ‘‘receiver’’ PFR-Ty1 cells in the oligo-
peptidase-induced co-infection were highly enriched for
stumpy forms (Figures 7B, 7C, and S7A). Moreover, analysis
of the relative proportion of ‘‘producer’’ and ‘‘receiver’’ cells in
each group demonstrated that the ‘‘producer’’ cells were
more affected than the ‘‘receiver’’ cells by the oligopeptidase
expression, as their overall levels diminished as a contribution
to the total parasitemia (Figure S7A). These observations are
all consistent with the hypothesis that secreted oligopeptidases
promote stumpy formation as a paracrine response in the
‘‘receiver’’ cells, and the producer cells are affected by their8 Cell 176, 1–12, January 10, 2019production of the peptidase in vivo, or
by a combination of a local autocrine
and paracrine response. We conclude,
therefore, that peptidases released by
trypanosomes in vivo can generate a
paracrine quorum sensing signal to
induce stumpy formation.
DISCUSSION
Our data reveal oligopeptide signaling
can promote trypanosome QS consistent
with the activity of the proposed stumpy
induction factor. This is based upon
several key discoveries; (1) a GPR89 fam-ily member with oligopeptide transport capability, (2) the surface
location of this protein on the parasite stage that receives the QS
signal, (3) the ability of ectopically expressed TbGPR89 and a
heterologous oligopeptide transporter to drive stumpy forma-
tion, (4) the capacity of specific oligopeptides to promote stumpy
formation in vitro, and (5) the ability of secreted oligopeptidases,
a normal part of trypanosome infection, to provide a paracrine
signal promoting stumpy production in co-infecting parasites.
Collectively, these provide a ‘‘signal’’ and ‘‘receptor’’ mechanism
for density sensing in trypanosome infections, processes that
have been the subject of speculation for over 20 years.
In both eubacteria and eukaryotes, diverse oligopeptides are
transported by promiscuous POT family proteins to provide
nutritional carbon or nitrogen sources for cells, these often
being generated by extracellular peptidases. POT family pro-
teins are also present in kinetoplastids, except the African
Figure 7. Peptidase-Expressing Blood-
stream Trypanosomes Generate a Stumpy-
Inducing Paracrine Signal
(A) Schematic representation of the experimental
regimen. Trypanosomes were induced to express
secreted peptidases under doxycycline regulation,
so generating an enhanced signal that promotes
stumpy formation (‘‘Producer line’’). Co-infection
with pleomorphic T. brucei cells with a Ty1 epitope
tagged PFR acts as a ‘‘receiver’’ cell line that can
be distinguished from ‘‘producer’’ cells via labeling
of the flagellum. Right: representative field
comprising ‘‘producer’’ cells (PFR) and ‘‘receiver’’
cells (PFR+) co-labeled or not with the stumpy
marker, PAD1 (green). Scale bar, 15 mm.
(B) Parasitemias of mice infected with the PFR-Ty1
cell line alone, or a coinfection of the PFR-Ty1 cell
line with the BIPN-TbPGP line either induced or not
to express the peptidase by doxycycline. Right:
percentage PAD1+ PFRTy1 divided by the overall
parasitemia revealing that the PFR-TY1 cells are
induced to become stumpy despite the low para-
sitemia of the coinfection when induced. Data are
derived from microscopic analysis of 2,000 cells in
each sample on day 5 of infection; for PFR-Ty1
cells, >250 cells were scored as PAD1+ or PAD1.
Error bars, SEM.
(C) Parasitemias of mice infected with the PFR-Ty1
cell line alone, or a coinfection of the PFR-Ty1 cell
line with the TbPOP line either induced or not to
express the peptidase by doxycycline regulation.
Right: percentage PAD1+ PFRTy1 cells divided by
the overall parasitemia revealing that the PFR-TY1
cells are induced to become stumpy despite the
low parasitemia of the coinfection when induced.
Data are derived from microscopic analysis of
2,000 cells in each sample on day 5 of infection; for
PFR-Ty1 cells, >250 cells were scored as PAD1+ or
PAD1. Error bars, SEM.
See also Figures S5, S6, and S7 and Tables S1, S2,
S3, and S4.
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POT gene has apparently been lost by gene deletion. These try-
panosomes all show density-dependent growth control in the
mammalian bloodstream (Shapiro et al., 1984; Silvester et al.,
2017; Vassella et al., 1997), this being linked to the develop-
ment of stumpy forms in T. brucei. We show that TbGPR89 is
an essential protein in trypanosomes that can replace the oligo-
peptide transport function of a conventional POT but also pro-
vides a density sensing role in trypanosome quorum sensing.
This dual function provides an elegant mechanism for signal
perception where TbGPR89 enables essential oligopeptide
uptake to the proliferating slender forms but also ensures there
is a single signal input for QS without interference from
additional oligopeptide uptake by a conventional POT. Anaccelerated developmental response
to ectopic overexpression of TbGPR89
may reflect increased sensitivity to the
signal, although oligopeptide trans-
porters may also be regulated by oligo-merization (Guettou et al., 2013; Newstead, 2015) to precipitate
differentiation. The intracellular oligopeptide specificity and
response remains to be dissected, but may link to TOR and
AMPK, which are regulators of trypanosome differentiation
(Barquilla et al., 2012; Saldivia et al., 2016).
Several peptidases are released by trypanosomes that accu-
mulate and are active in the bloodstream during infections
(Bossard et al., 2013; Moss et al., 2015). These and additional
host peptidases degrade numerous host substrates, to generate
diverse oligopeptide signals that may be transported by
TbGPR89. Here, we demonstrated that two released pepti-
dases, prolyl oligopeptidase (TbPOP) (Bastos et al., 2010) and
pyroglutamyl peptidase (TbPGP) (Morty et al., 2006), increase
stumpy formation. We show that TbPOP is secreted byCell 176, 1–12, January 10, 2019 9
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secretory material of the parasite (Geiger et al., 2010). Further-
more, although TbPGP is normally released by lysed trypano-
somes, we observed enhanced stumpy formation when this
protein is modified to enhance its secretion. That both pepti-
dases generated the paracrine signal suggests, therefore, that
common products, generated directly or after further processing
in the blood, contribute to the signal.
Oligopeptides are enriched in both trypanosome conditioned
medium (Creek et al., 2013) and the serum of infected patients
(Vincent et al., 2016). Supporting this, we show that TbPGP
and TbPOP degrade serum proteins (Figure S7C; Tables S1
and S3), and addition of oligopeptide mixtures to trypanosome
media promotes stumpy formation of pleomorphic trypano-
somes but not monomorphic parasites that are QS-signal blind.
The nature of the defect in these monomorphic cells remains to
be discovered but is not at the level of TbGPR89 because this
protein is essential in bloodstream form parasites.
Both TbPGP and TbPOP exhibit activities that may be relevant
for trypanosome QS. Thus, TbPGP degrades pyroglutamyl
groups on serum peptides such as thyroid releasing hormone
(TRH) or gonadotrophin-releasing hormone (GnRH), an activity
we have confirmed in human and bovine serum (Table S1), and
many additional TbPGP-generated products were detected
that will require extensive further analysis for unambiguous iden-
tification (Table S2). TbPOP can also act on bioactive peptide
hormones as well as abundant host collagen and proline-rich
proteins in serum (Bastos et al., 2010) (Tables S3 and S4). Using
synthetic di- and tripeptide libraries, we have further established
that there is specificity to the oligopeptide signal with selectivity
for several tripeptide sublibraries, and some members of these
are detected as direct products of the secreted peptidases
in serum.
The ability of exogenous oligopeptides and secreted pepti-
dases to induce premature differentiation in vivo supports a
role for oligopeptides in inter-cellular QS.Moreover, the absence
of an effect of TbGPR89 expression in developmentally incom-
petent parasites (monomorphs and RBP7-depleted cells), and
the accelerated differentiation of a co-infecting ‘‘receiver’’ line
demonstrates that the developmental response is not a conse-
quence of the action of intracellular peptidase trafficking or activ-
ity at the expresser cell surface. Indeed, the expressed VSG
remains intact (Figure S7B), arguing against a SIF-independent
differentiation response activated by perturbation of the surface
coat (Zimmermann et al., 2017). Instead, our data suggest a
model where released peptidases act as public goods (Brown
and Taddei, 2007) to generate a paracrine oligopeptide signal
that can promote differentiation. This is consistent with the re-
ported properties of SIF (<500 Da, heat stable) but differs from
the anticipated characteristic of SIF as a directly released
metabolite or small molecule (Vassella et al., 1997).
A ‘‘stumpy induction factor’’ signal generated in the environ-
ment by the release of parasite proteases is consistent with
environmental sensing in other organisms and the biological
characteristics of trypanosome infection in vivo. For example, a
recently reported fungal signaling system is dependent upon
the release of extracellular oligopeptidase (Homer et al., 2016),
and in Bacillus cereus, QS signaling operates by the extracellular10 Cell 176, 1–12, January 10, 2019processing of the autoinducing peptide by a secreted neutral
peptidase B, and then import by an oligopeptide permease (Laz-
azzera andGrossman, 1998). The local production of peptidases
is also compatible with the generation of stumpy forms when
parasites are constrained in the host dermis (Capewell et al.,
2016) or adipose tissue (Trindade et al., 2016) as well as at
high density in the bloodstream circulation of infected mice.
This is because both environmental flow and cell density would
determine the concentration of oligopeptide signals generated,
with tissue-resident parasites in a low flow environment and in
close proximity to peptidase substrates (Caljon et al., 2016) pre-
dicted to differentiate at lower density than circulating parasites
in a high flow blood environment. Such local effects can also
explain how livestock trypanosome infections can sustain trans-
missibility while exhibiting low bloodstream parasitemia. Im-
mune-mediated parasite killing could also boost the generation
of transmission stages through peptidase release from dying
parasites.
Our results have implications for two potential therapeutic ap-
proaches. First, the delivery of a stable oligopeptide signal to
promote premature stumpy formation could generate an anti-
virulence ‘‘quorum-sensing interference’’ approach if compre-
hensively and systemically active. Alternatively, our discovery
that a GPR89 family protein is required for cell viability and
cell-type differentiation provides opportunities for pharmacolog-
ical intervention. GPCR-like proteins as well as multi-membrane
spanning transporters and transceptors are highly targeted in
drug discovery programs, with nearly 40% of current drugs
focused on this family of proteins. In particular, the functions of
TbGPR89 in both slender form viability and parasite stumpy
formation provides an evolution-proof double lock to prevent
the emergence of drug-resistance, since any viable drug-resis-
tant mutants bypassing TbGPR89 would be unable to spread
through their transmission incompetence.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Trypanosome infections were carried out in female healthy outbred MF1 mice at least 10 weeks old, immunocompromised with
25 mg/ml cyclophosphamide delivered intraperitoneally 24 h prior to trypanosome infection. No blinding was performed and the an-
imals were not subject to previous procedures or drug treatment. Animal experiments were carried out according to the United
KingdomAnimals (Scientific Procedures) Act under a license (PPL60/4373) issued by the United KingdomHomeOffice and approved
by the University of Edinburgh local ethics committee. Animals were kept in cages containing 1-5 mice on a 12h daylight cycle and
maintained at room temperature. Between 2 and 3 mice were used per group; groups usually involved induction of ectopically ex-
pressed gene expression- this being activated by inclusion of doxycycline (200 mg/ml in 5% sucrose) provided in the drinking water,
with control mice being provided with 5% sucrose alone. Parasitemias were estimated using a ‘rapid matching’ method involving
visual comparisons of live parasites in blood by microscopy with a published standardized chart of parasite numbers per ml (Herbert
and Lumsden, 1976).
Trypanosomes
Trypanosoma brucei EATRO 1125 AnTat1.1 90:13 (TETR T7POL NEO HYG) parasites were used throughout (Engstler and Boshart,
2004) for all pleomorphic cell analysis. For monomorphic trypanosome analysis, T. brucei Lister 427 90:13 (TETR T7POL NEO HYG)
(Wirtz et al., 1999) cells were used. In vitro, parasites were grown in HMI-9 medium (Life technologies) (Hirumi and Hirumi, 1989) at
37C 5% CO2.
METHOD DETAILS
Experimental design
Experiments were carried out without blinding or randomization/stratification. All figures include information on the replicate number
for each experiment. Experiments were also validated in additional pilot experiments or independent replicates. Statistical methods
were carried out as detailed under ‘QUANTIFICATION ANDSTATISTICAL ANALYSIS’ and no data were excluded. For the analysis of
phenotypes 3 animals per treatment were routinely used for analysis. Our previous analyses (e.g., Mony et al., 2014) indicate that this
sample size is sufficient to detect differences between cell lines and treatment groups. In the current manuscript, the visual analytical
assays applied (manual scoring by microscope) to the different treatments and groups (cell cycle scoring, analysis of PAD1 staining,
scoring of flagellar labeling, morphological analysis) required analyses to be limited to 2 animals per group in mixed infection exper-
iments. P values of less than 0.05 were considered statistically significant.
Parasite transfection
Parasite transfection was by Amaxa nucleofection according to previous detailed methods for monomorphic (Bu¨hlmann et al., 2015)
or pleomorphic (MacGregor et al., 2013) parasites.
Plasmid construction and cell line generation
The TbGPR89 (TriTrypDB: Tb927.8.1530), TbPGP (TriTrypDB: Tb927.4.2670) and TbPOP (TriTrypDB: Tb927.10.8020) open reading
frameswere amplified from T. brucei EATRO 1125 AnTat1.1 wild-type genomic DNAwith appropriate primers (Table S5) with terminal
restriction sites for insertion into the pDex577-Y vector for tetracycline-inducible overexpression with an C-terminal TY epitope tag.
The resulting overexpression constructs were linearized with NotI and transfected into Trypanosoma brucei EATRO 1125 AnTat1.1
90:13 (Pleomorphs) or Lister 427 90:13 (monomorphs) cells. Several independent cell lines were isolated and their growth analyzed
in vitro or in vivo in the presence or absence of tetracycline, or doxycycline, respectively. Expression was confirmed by western blot-
ting using an anti-TY antibody. To generate the BIP-PGP contruct, the BIP N-terminal sequence was amplified from T. brucei
genomic DNA and subcloned into the pDEX-PGPty plasmid at the N terminus with the appropriate restriction enzymes. The Bacterial
YjdL gene (Escherichia coli str. K-12 substr. W3110) was amplified from BL21 genomic DNA and cloned into the pDex577-Y plasmid
for integration into T. brucei pleomorphic cells. For site directed mutagenesis, the QuikChange II Site-Directed Mutagenesis Kit was
used (Agilent). For generation of conditional KOs of GPR89, Trypanosoma brucei EATRO 1125 AnTat1.1 90:13 were transfected with
pLEW100cre-EP1 containing the Cre recombinase. The GPR89 gene was cloned into pyrFEKO-PUR plasmid (containing 50 and 30
GPR89 UTRs) and transfected into T. brucei EATRO 1125 AnTAT 90-13 Cre cells. Subsequently, the second GPR89 allele was
targeted using pyrFEKO-BSD. Analysis of Cre induction was carried out according to Kim et al. (2013). Thus, induction of Cre
with Doxycycline acts to remove both the BSD-TK cassette and the GPR89ty-Puro-TK allele, generating a null mutant. Null mutantsCell 176, 1–12.e1–e6, January 10, 2019 e3
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To enable the use of CRISPR tools in T. brucei pleomorphic cells, we introduced into T. brucei EATRO 1125 Antat 1.1 cells
the pJ1339 plasmid (a derivative from pJ1173, gift from Dr. Jack Sunter, Oxford Brookes University, UK; unpublished) that
carries a single resistance marker, puromycin, the tet repressor, T7 RNA polymerase and Cas9 (Beneke et al., 2017). Expression
of Cas9 is constitutive. To replace the endogenous copy of GPR89, the N67Q mutant was cloned into pPOTv6 using HindIII and
BamHI. For gene replacement with pPOTv6-GPR89-N67Q (Blasticidin) and pPOTv7 (Hygromycin) constructs, 107 cells were trans-
fected with the PCR reactions for the two sgRNAs and two donor DNAs (combined volume approx. 100 ml) in a total volume
of 250 ml.
Cell cycle analysis
Methanol-fixed blood smears were rehydrated in phosphate-buffered saline (PBS) for 5 min. Slides were stained with 30 mL of 4’,
6-diamidino-2-phenylindole (DAPI; 10 mg/ml in PBS) for 2 min in a humidity chamber and were then washed for 5 min in PBS. Slides
were then mounted with 40 mL Mowiol containing 2.5% 1, 4-diazabicyclo(2.2.2)octane (DABCO). 250-500 cells were counted per
sample and per time point except where there was very low parasitaemia, where 200 cells were counted.
Flow cytometry
2-5x106 cells were washed twice in PBS prior to fixing in 500 mL 2% formaldehyde/0.05% glutaraldehyde > 1h at 4C. Cells were then
washed 3x in PBS and resuspended in 2%BSA:PBS for 30 min. Cells were then resuspended in primary antibody diluted in 2%
BSA:PBS (aEP procyclin (Cedar Lane laboratories) was diluted 1:500) and were incubated overnight at 4C. The cells were washed
twice in PBS andwere resuspended in secondary antibody diluted in 2%BSA:PBS (a-mouse FITCwas diluted 1:1000). The cells were
washed twice in PBS and were resuspended in 500 mL PBS containing 0.02 mg/ml DAPI. Samples were then processed on an LSRII
flow cytometer (BD Biosciences). Positive controls and secondary antibody only controls were included. Analysis was performed
using FlowJo software (Tree Star).
Western blotting
An antipeptide antibody recognizing TbGPR89 amino acids LDASQVSERIKSNFS was generated in rabbits (Eurogentec). For detec-
tion of GPR89, cells were resuspended in ice-cold 1 mM TLCK (Na-Tosyl-L-lysine chloromethyl ketone hydrochloride, Sigma) at
1x108 cells/ml and incubated on ice for 5 minutes then incubated 37C for a further 15 minutes, and then diluted with to 1X with
4X 8Murea loading buffer without DTT. Protein sampleswere resolved on SDS-PAGE gels and blotted onto nitrocellulosemembrane.
Primary antibody dilutions were prepared in 1% BSA/TBS and the membrane was incubated overnight. aGPR89 antibody was used
at 1:1000, aBB2 antibody (Bastin et al., 1996) was used at 1:20 to detect the TY-tagged TbGPR89, aPAD1 antibody (Dean et al., 2009)
was used at 1:1000 and aEF1 (elongation factor 1-alpha, MerckMillipore 05-235) was used for loading controls at 1:7000. Secondary
antibodies were diluted in 50% TBS and 50% Li-Cor blocking buffer. Both anti-mouse (IRDye 680 goat anti-mouse, Li-Cor) and
anti-rabbit (goat anti-rabbit IgG (H+L) Dylight 800, Thermoscientific) secondary antibodies were diluted 1:7000. Signal was detected
on a Li-Cor Odyssey imaging system.
In vitro differentiation to procyclic forms
Parasites were resuspended at 2x106/ml in SDM79 media (GIBCO by Life technologies) containing 6mM cis-aconitate (Sigma,
A3412) and were incubated at 27C. Samples were collected for flow cytometry at 0h, 3h and 6h. Progression to procyclic forms
was monitored by their expression of EP procyclin using flow cytometry as detailed above.
MitoTracker assays
Bloodstream-form trypanosomes (2-3x106/ml) were incubated in HMI-9-medium containing 100 nM MitoTracker Red CMXROS
(Molecular Probes) for 30 min at 37C. Then the cells were washed with HMI-9 and incubated for a further 20 min in the absence
of MitoTracker, after which the parasites were fixed for 2 min at 4C with 0.4% paraformaldehyde (prepared fresh in PBS). The cells
were then washed once with PBS and air-dried smears were prepared. The slides were fixed for 10 min in methanol at 20C, before
rehydration for 10 min in PBS, followed by DAPI staining and mounting in MOWIOL.
Expression in E. coli
A single colony of E. coli BL21-CodonPlus (DE3)-RIPL cells containing the plasmids pET28a- (TbGPR89, YjdL, TbGPR89-TYR48) or
empty pET28a was inoculated in 3 mL LB media containing 100 mg/mL kanamycin and 34 mg/mL chloramphenicol and allowed to
grow overnight. Overnight cultures were transferred to 10 mL LB media with the same amount of antibiotics using a dilution of
1:50. The cells were allowed to grow until OD600 of 0.6–0.8 before induction with 1 mM IPTG. The cells were harvested 3 h after
induction with IPTG at 37oC.e4 Cell 176, 1–12.e1–e6, January 10, 2019
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Uptake assays were performed with bacteria 3 h after induction with IPTG with the fluorescent dipeptide b-Ala-Lys-AMCA (Biotrend,
Cologne, Germany). Cells were harvested by centrifugation (2500 x g, 5min) to anOD600 of 10 and incubated in Assay Buffer (33mM
HEPES, 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4 and 5 mM glucose, pH 6.5) at room temperature for at least
20 min. In a final volume assay of 100 ml, 1.5 mL of a 20 mM b-Ala-Lys-AMCA stock solution (final concentration 500 mM) in the pres-
ence of absence of competing Di- or Tripeptide sublibraries, or with 40mMcarbonyl cyanide m-chlorophenyl hydrazone (CCCP), was
incubated with 40 mL bacteria cells at 37C. Uptake was determined over 15-20minutes. Following centrifugation and washing twice
in Assay-buffer, the cell pellet was suspended in 100 mL modified Assay buffer and the uptake was quantified by fluorescence
measurements (excitation at 340 nm and emission at 460 nm) on a Varioscan fluorimeter. Non-specific uptake control experiments
were performed under the same conditions and procedures as described above using E. coli BL21-CodonPlus (DE3)-RIPL cells
transformed with the empty pET28a vector.
Dipeptide and tripeptide sublibrary synthesis
The dipeptide and tripeptide libraries were synthesized by standard Fmoc Solid Phase Peptide Synthesis via split-and-mix. Rink
Amide TentaGel beads (100 mg per sublibrary, 0.22 mmol/g, 90 mm, Rapp polymer) were used for the synthesis. The amino acids
used for library production were: Ala, Arg, Asn, Asp, Gln, Glu, His, Leu, Lys, Phe, Pro, Ser, Thr, Trp, Tyr and Val. Beads were swollen
in dichloromethane for 10 min prior to coupling of Fmoc deprotection. After every synthesis step, coupling or Fmoc deprotection the
beads were washed with dimethylformamide and dichloromethane. A TNBS test was performed after each step. The Fmoc amino
acids (3 eq) were coupled in the presence of HATU (2.9 eq) and DIPEA (6 eq) in DMF (10 ml/mg of resin) for 20 minutes and the pro-
cedure repeated twice. The Fmoc groups were removed by shaking the beads twice for 15 minutes in a solution of 20% piperidine in
DMF (10 ml/g of resin). The peptides were cleaved in a solution of 95% trifuoroacetic acid (TFA), 2.5% triisopropylsilane (TIS) and
2.5%water for 4 h. The solvent was removed in vacuo and the samples re-dissolved in water and lyophilised. The libraries were sepa-
rated in sublibraries depending on the N-terminal amino acid (2 – 11mg) were finally dissolved in dry DMSOat 500mMconcentration.
All library concentrations for growth and differentiation assays were derived from the average molecular mass of the amino acids
contained.
Di-and Tripeptide library and peptone assays
Trypanosoma brucei EATRO 1125 AnTat1.1 90:13 parasites were incubated with varying concentrations of each sublibrary of di-or
tripeptides (ranging from 500 mM to 62.5 mM) in 2 mL wells. The starting parasite density was 1x105 parasites/ml. After 48 and 72 h,
cell were counted by hematocytometer and samples were taken and fixed with 4% paraformaldehyde, and assessed for PAD1
expression. Similarly, peptone broths (Brain heart infusion, Peptone from animal proteins, Proteose peptone, Vegetable Special infu-
sion, peptone from Gelatin - Sigma-Aldrich- or Tryptose -Fluka) were prepared according to the manufacturers’ instructions, and
different concentrations tested in T. brucei EATRO 1125 AnTat1.1 90:13 cultures. After 48 hr, samples were taken and assessed
for PAD1 expression.
Metabolite analysis of TbPGP or TbPOP treated human and bovine serum
Samples of human and bovine serum incubated overnight at 37C in the presence or absence of TbPGP, were centrifuged for
10 minute at 13000 g and the supernatant passed through a 3000 Da cut-off centrifugal filter membrane (Amicon Ultra-0.5). The
filtrate was diluted with methanol and analyzed using an Orbitrap Mass Analyzer (80-1000 Da range, positive and negative mode).
Additionally, the masses detected in each sample were screened against the monoisotopic masses of pyroglutamate and a range
of commonly occurring pyroglutamate-containing serum proteins. The intensity of the free pyroglutamate signal was significantly
greater in all serum samples treated with TbPGPase (negative mode) while the pGlu peptides, TRH and TRH-like peptide (detected
in positive mode), were present in control serum but absent from samples treated with TbPGPase (highlighted cells).
For TbPOP, samples of human and bovine serum incubated overnight at 37C in the presence or absence of enzyme were centri-
fuged for 10 minute at 13000 g and the supernatant passed through a 3000 Da cut-off centrifugal filter membrane (Amicon Ultra-0.5).
The filtrate was diluted withmethanol and analyzed using anOrbitrapMass Analyzer (80-1000Da range, positive and negativemode).
Structural modeling
The i-TASSER server (Yang et al., 2015) was utilized to generate amodel using the sequence of TbPOT; chain A of structure 4IKZwas
specified to be used as the template. TbPOT residues equivalent to template substrate-binding residues were visually identified and
prioritised for mutational analysis.
Bioinformatic analysis
The evolutionary history of GPR89 cDNA sequenceswas inferred using the Neighbor-Joiningmethod (Saitou andNei, 1987) following
multiple sequence alignment using MUSCLE (Edgar, 2004). The percentage of replicate trees in which the associated taxa clustered
together in the bootstrap test (1000 replicates) are shown next to the branches in the generated trees (Felsenstein, 1981). The trees
are presented to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic
tree. The evolutionary distances were computed using the Poisson correction method (Zuckerkandl and Pauling, 1965) and are in theCell 176, 1–12.e1–e6, January 10, 2019 e5
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analyses were conducted in MEGA7 (Kumar et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
Graphical and statistical analyses were carried out in GraphPad Prism version 6 (GraphPad Software, La Jolla, California, USA,
https://www.graphpad.com) by two-way repeated-measures ANOVA test followed by Bonferony post hoc analysis. For individual
experiments, n values are included in the Figure legend; graphs provide mean values ± SEM.e6 Cell 176, 1–12.e1–e6, January 10, 2019
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Figure S1. GPR89 Family Members in Kinetoplastid Organisms, Related to Figure 1
(A) Phylogenetic tree of GPR89 family representatives in eukaryota. Human GPR89, Arabidopsis GTG1/GTG2 and Trypanosoma GPR89 are highlighted. The
optimal tree with the sum of branch length = 7.35 is shown. The analysis involved 15 amino acid sequences. All positions containing gaps and missing data were
eliminated. There was a total of 383 positions in the final dataset. Accession numbers for each species are; H. sapiens, NP_001091081; T. adhaerens,
XM_002112150; D. melanogaster; NP_611016; C. elegans, NP_499588 ; D.discoideum, XM_633754; A thaliana GTG1, NP_001031235; C. reinhardtii,
XM_001695842;C. velia, Cvel_25352; T. gondii, TGME49_286490; P. tartaurelia, XM_001426347; P. falciparum, PF3D7_1008500; P. vivax, PV_094620 ; L. major,
LmjF_07.0330.
(B) Phylogenetic tree of GPR89 family representatives in the kinetoplastids. The optimal tree with the sum of branch length = 4.48 is shown. The percentage of
replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next to the branches (Felsenstein, 1981). The tree
is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The analysis involved 18 amino
acid sequences. All positions containing gaps andmissing data were eliminated. There are a total of 302 positions in the final dataset. The tree is shown rooted on
the Bodo saltans GPR89 sequence. B. saltans is a free-living nonparasitic marine kinetoplastid of the bodonid clade from which trypanosomatids descended
(Jackson et al., 2016).
(C) Domain structure of GPR89members in the kinetoplastida highlighting the position of predicted transmembrane domains (red) Pfam domain 12537 (gray) and
Pfam domain 12430 (green).
Figure S2. Cre-lox Strategy for the Deletion of TbGPR89, Related to Figure 2
(A–D) For cre-lox based gene deletion, the TbGPR89 gene locus was initially disrupted by integration of a BSD gene and thymidine kinase (TK) flanked by LoxP
sites in a cell background capable of doxycycline inducible cre recombinase expression (A). After recombinase induction (+DOX) and ganciclovir (GCV) selection
to derive single allele replacements, the cells were transfected with a further loxP-flanked cassette with a TbGPR89 gene linked to a puromycin (PURO) resistance
cassette and thymidine kinase (TK), and selectant lines isolated based on their puromycin resistance. Upon doxycycline-mediated cre recombinase induction
(+DOX, B) the cells grewmore slowly and the expression of both TbGPR89 and puromycin was reduced, indicating deletion of the LoxP flanked cassette in some
cells in the population (C). However, when null mutants were selected by cre recombinase induction in the presence of ganciclovir (GCV), the population initially
grew but then died after 5 days, when TbGPR89 protein was lost by division (D). Uninduced cells were killed by Gancyclovir through their TK expression.
Figure S3. GPR89 Mutants Do Not Drive Stumpy Formation, Related to Figure 2
(A) Schematic representation of different domains mutated within TbGPR89.
(B–D) Growth of pleomorphic parasites induced or not to express TbGPR89 with a C-terminal truncation (TbGPR89 DC, B), a deleted loop region (TbGPR89 D
loop; C), or a mutated predicted N-glycosylation site (TbGPR89 N67Q ; D). In C and D, cultures were diluted at 48h to keep cell numbers below 2x106/ml. Error
bars = SEM.
(E) protein expression of TbGPR89 mutants in the respective cells lines in panels B-D at 4h post induction and, for the N glycosylation site, at 4h and 24h. In each
case, the loading control is EF1a. The detected protein in the TbGPR89DC samples is reduced because of the presence of fewer viable cells after induction of the
ectopic protein expression.
(F) Allelic replacement of wild-type TbGPR89 with TbGPR89 N67Q by CRISPR. One TbGPR9 allele was replaced with the TbGPR89 N67Q mutant (linked to a
blasticidin resistance gene) and the other with a hygromycin resistance gene. Analysis of two resulting clones (Clone A, Clone B) showed retention of a wild-type
TbGPR89 gene copy, validated by PCR (not shown) and sequence analysis, where both the mutant and wild-type sequence are detected. PCR using primers
targeting flanking sequences demonstrated that themutant allele and hygromycin resistance cassette integrated at the expected genomic location; the additional
wild-type allele genomic location has not been mapped, but retains the endogenous 30UTR (not shown).
(legend on next page)
Figure S4. TbGPR89 Is an Oligopeptide Transporter, Related to Figure 3
(A) iTASSER output following submission of the TbGPR89 sequence in September 2015. The description of the top 10 identified structural analogs is shown in the
‘call out’ box.
(B) Structural homology between TbGPR89 and structure 4ikvA derived from the Geobacillus kaustophilus POT oligopeptide transporter. The G. kaustophilus
template (PDB: 4IKZ) is shown as secondary structure and colored accordingly, with side chains of the residues of the alafosfalin binding pocket shown as lines
and the ligand as sticks. The TbGPR89 model is shown on the right, with equivalent ligand binding pocket residues shown as sticks. Note that the overall model
misrepresents the intracellular domain of TbGPR89 as an additional 5TMs because the threading forces a match to the 14 TMs in theGeobacillus POT (and other
threaded transporters identified by iTASSER).
(C) Expression of TbGPR89 generates time and concentration dependent dipeptide uptake when expressed in E. coli. E. coli were induced to express TbGPR89
under IPTG induction and monitored for their uptake of b-Ala-Lys-AMCA (measured in arbitrary fluorescence units). The left panel shows uptake of fluorescent
dipeptide by TbGPR89 when expressed in E. coli is not saturable up to 4mM, consistent with transport but not binding. +IPTG, TbGPR89 expression
induced; -IPTG, TbGPR89 expression not induced; the right panel shows the uptake of 200mM b-Ala-Lys-AMCA at 15 min, 30 min and 60min after addition. Error
bars = SEM. *p = 0.006; **p% 0.0001.
(D) Inhibition of florescent dipeptide uptake by TbGPR89 or E. coli YjdL in the presence of CCCP which inhibits proton gradient-dependent transport.
(E) Fluorescent dipeptide uptake by TbGPR89 at 4C, 20C or 37C over 15 minutes. Dipeptide uptake is enhanced at 37C with respect to 4C and 20C,
reflective of uptake rather than binding.
Figure S5. Oligopeptidase Expression in Trypanosomes, Related to Figure 7
(A) Expression TbPGP or BiPN-TbPGP in vitro. Panels show the growth of parasites ± induction to express BiPN-TbPGP (left panel) or TbPGP (right panel) in vitro
(n = 3). In each case expression does not affect the growth of the cells. Error bars = SEM. Inset western blots are shown to confirm protein expression with the
BIPN fusion resulting in a larger protein.
(B) Expression of BiPN-TbPOP or TbPOP in vitro. The panels show the growth of parasites ± induction to express BiPN-TbPOP (left panel) or TbPOP (right panel)
in vitro (n = 3). In each case expression slows the growth of the cells. Error bars = SEM. Inset western blots show the induced expression of TbPOP and the
expresison of the stumpy marker PAD1, which is present on the high density parasites not induced to express TbPOP and the low density parasites induced to
express TbPOP.
(C) Western blot demonstrating the extracellular release of TbPOP detected in the culture supernatant (S) with TbPOP in the absence of a BIPN secretory signal;
samples were prepared after 1h or 2hr incubation in Creek’s minimal mediumwithout serum (Creek et al., 2013) with TbPOP expression being induced or not with
doxycycline. Tubulin remains in the pellet (P) fraction showing that there is no cell lysis.
Figure S6. Oligopeptidase Expression In Vivo Drives Stumpy Formation, Related to Figure 7
Growth of parasites induced to express BIPN-TbPGP, TbPGP or TbPOP in vivo. In each case the parasitemias are shown of equivalent numbers of parasites
inoculated to initiate the infection, doxycycline being provided to themice from day 1 of infection. In all cases there is reduced growth upon peptidase expression,
this being more pronounced and consistent for BIPN-TbPGP than TbPGP. TbPOP was only analyzed without a BIPN leader, because the protein is naturally
secreted (Figure S5C). Each growth profile represents analysis of duplicate or triplicate infections for each condition. Error bars = SEM. The western blot
demonstrates inducible TbPOP expression, with the expression of the stumpy marker PAD1 being present on the high density parasites not induced to express
TbPOP and the low density parasites induced to express TbPOP. EF1 alpha provides a loading control. M; mouse.
Figure S7. Oligopeptidase Expression Generates a Paracrine Signal Driving Stumpy Formation, Related to Figure 7
(A) Coinfection of BIPN-PGP or TbPOP expressing cells (‘Producers’) with PFR-Ty1 pleomorphic parasites (‘receivers’). The histograms represent the % PAD1
cells for each cell type. PFR1-Ty1 cells express high levels of PAD1 at high parasitaemia (either when in a monoinfection or when co-infected with the producer
line not induced to express the peptidase). With peptidase induction, the overall parasitemia is much lower (Figure 7) but high levels of PAD1 expression are
expressed on the ‘receiver’ PFR-Ty1 line. The relative proportion of producer and receiver cells was also determined by microscopical scoring of the number of
parasites with a labeled flagellum after reaction with the Ty1 specific antibody BB2, with at least 2000 cells analyzed in each infection, except the monoinfection
with PFR-Ty1 cells alone (where all cells were PFR labeled from an analysis of at least 250 cells). The relative proportion of PFRTy1 cells was higher upon
peptidase induction reflecting either reduced growth of the producer cells upon peptidase expression or a combination of autocrine and paracrine induced arrest
in the producer cells, while receiver cells only exhibit a paracrine response to the induced peptidase expression.
(B) The western blot detects the stumpymarker PAD1, which is present on the high density parasites not induced to express TbPOP and the low density parasites
induced to express TbPOP, as well as the high density PFR-ty tagged cells alone. BB2 detects the epitope tag present on the PFR-Ty1 tagged ‘recipient cell line’,
(legend continued on next page)
EF1alpha provides a loading control and the AnTat1.1 lanes demonstrate the integrity of the VSG regardless of the expression of the TbPOP peptidase by the
producer cells.
(C) Samples of human and bovine serum were mixed with an equal volume of standard PGPase assay buffer (50 mM HEPES, 1 mM EDTA and 10 mM DTT) and
incubated overnight at 37C with either recombinant TbPGP (5ml per 100ml) or an equivalent volume of assay buffer. When centrifuged following incubation,
significant-sized, gelatinous (‘clot-like’) pellets were formed in the human serum samples which had been incubated without TbPGP; these pellets were much
smaller in the samples incubated with TbPGP and were virtually absent from the bovine serum samples. The pellets were solubilised in equal volumes of
SDS-PAGE loading buffer and analyzed by SDS-PAGE (see below). The pellets appeared to be composed of bulk serum proteins with no obvious enrichment for
specific proteins, however, the total amount of protein was clearly much reduced in the human serum samples which included TbPGPase.
